✦ LIBER ✦

Concerns about the design of clinical trials for spinal muscular atrophy

✍ Scribed by Thomas O. Crawford

Book ID: 116792195
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 73 KB
Volume: 14
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2004.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Observational study of spinal muscular a

Observational study of spinal muscular atrophy type I and implications for clinical trials

✍ Finkel, R. S.; McDermott, M. P.; Kaufmann, P.; Darras, B. T.; Chung, W. K.; Spro 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 481 KB

Molecular Therapeutic Strategies for Spi

Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials

✍ Zanetta, Chiara; Nizzardo, Monica; Simone, Chiara; Monguzzi, Erika; Bresolin, Ne 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 524 KB

Clinical Trials in Spinal Muscular Atrop

Clinical Trials in Spinal Muscular Atrophy: Protocol Development and Reliability of Quantitative Strength Assessment Method

✍ Barker, L.; Smith, C.; Perkins, B.; Burhans, K.; Newman, R.; Zimmerman, L.; Cook 📂 Article 📅 1992 🏛 SAGE Publications 🌐 English ⚖ 600 KB

SMA-EUROPE workshop report: opportunitie

SMA-EUROPE workshop report: opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe

✍ Nathalie Kayadjanian, Arthur Burghes, Richard S Finkel… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 138 KB

Prospects for the gene therapy of spinal

Prospects for the gene therapy of spinal muscular atrophy

✍ Marco A. Passini; Seng H. Cheng 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Antisense Oligonucleotides for the Treat

Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy

✍ Porensky, Paul N.; Burghes, Arthur H.M. 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 388 KB